港A兩市遊戲股走高 3月份27款進口遊戲過審 專家稱版號發放趨於穩定
格隆匯3月21日丨港A兩市遊戲股走高,港股方面,嗶哩嗶哩升超8%,心動公司升超2%,中手遊跟升;A股方面,天娛數科、崑崙萬維升超6%,姚記科技、冰川網絡升超4%,順網科技、三七互娛升超3%。國家新聞出版署昨日發佈了2023年進口遊戲審批信息,共計27款進口遊戲過審。統計過去三年進口遊戲版號發現,2020年進口版號全年發放數量97個,2021年鋭減至76個,2022年則降至44個。艾媒諮詢CEO兼首席分析師張毅表示,2022年進口遊戲版號僅發放了一次,今年進口遊戲版號在3月份公佈,預示着今年或將再次發放進口遊戲版號,無論在頻次還是數量上,版號發放都已趨向穩定。


Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.